Pharmacokinetics Part II Berhanemeskel W.G. Assistant Professor Pharmaceutics Department School of Pharmacy College of Medicine and Health Sciences University of Gondar Gondar…
Clinical Pharmacokinetics Janice E. Sullivan, M.D. Brian Yarberry, Pharm.D. Why Study Pharmacokinetics (PK) and Pharmacodynamics (PD)? Individualize patient drug therapy…
Slide 1Useful revision guide Instant Clinical Pharmacology E.J. Begg Useful information on individual drugs (although a bit old now) Basic Clinical Pharmacokinetics (2 nd…
Slide 1DRUG TOXICITY Dr. Peter Maskell [email protected] Slide 2 Toxicology is the science that deals with the amount of an agent that causes an adverse action in…
1.Women, Aging andMental HealthDr Cathy SheaAssociate ProfessorChair, Division of Geriatric PsychiatryUniversity of Ottawa2. Topics we will cover Demographics of aging…
1. BIOAVAILABILITYDr. JEEVAN JACOBJunior ResidentDept. of Pharmacology 2. Definition“The rate and extent to which the activeingredient or active moiety is absorbedfrom…
1. Non-Linear Pharmacokinetics Non-linear pharmacokinetic models, as opposed to linear pharmacokinetic models differ in some very critical areas. When the concentration that…
1. PharmacokineticsPharmacokinetics DistributionDistribution 2. Distribution of drugsDistribution of drugs When a drug is administered, it does not achieve an equal concentration…
1. I . TAMMI RAJU BIOMARKERS IN ACS 2. DEFINITION Biomarkers are measurable and quantifiable biological parameters which serve as indices for health and physiology assessment.…